5-Aminolevulinic Acid for Photodynamic Diagnosis of Malignant Glioma | MicrobiomeTrials← Back to trialsNCT06160492
5-Aminolevulinic Acid for Photodynamic Diagnosis of Malignant Glioma
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-04-14Est. Completion: 2027-12
Enrollment target: 79 participants Locations- Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
- Henan Province Tumor Hospital, Zhengzhou, Henan, China
Other microbiome trials you might be interested in
Cervical Intraepithelial Neoplasia Grade 3
This is a prospective, multicenter, biomarker-guided Phase II study evaluating the efficacy and safety of hexaminolevuli…
Wuhan, ChinaEst. completion Jun 2028
Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
This is a prospective, observational, multicenter real-world study designed to evaluate the effectiveness and safety of …
Multiple LocationsEst. completion Dec 2028